Assignee
NIMMUNE BIOPHARMA INC
US·5 granted patents·3 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
8 records- 0193US2026076962A1Lanthionine synthetase c-like 2-based therapeuticsNIMMUNE BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 0284US12502388B2Lanthionine synthetase C-like 2-based therapeuticsNIMMUNE BIOPHARMA INC·Filed 2022·Granted Dec 23, 2025·0 cites·20 claims
- 0384US2025163017A1Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameNIMMUNE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0480US2025163377A1Therapies with lanthionine c-like protein 2 ligands and cells prepared therewithNIMMUNE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0576US12145920B2Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameNIMMUNE BIOPHARMA INC·Filed 2022·Granted Nov 19, 2024·0 cites·19 claims
- 0673US12281096B2Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)NIMMUNE BIOPHARMA INC·Filed 2022·Granted Apr 22, 2025·0 cites·16 claims
- 0771US12150961B2Therapies with lanthionine C-like protein 2 ligands and cells prepared therewithNIMMUNE BIOPHARMA INC·Filed 2021·Granted Nov 26, 2024·0 cites·15 claims
- 0870US12391673B2LANCL ligandsNIMMUNE BIOPHARMA INC·Filed 2022·Granted Aug 19, 2025·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when NIMMUNE BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →